Related Experiment Videos

Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5

K Baumann1, E M Mandelkow, J Biernat

  • 1Max-Planck Unit for Structural Molecular Biology, Hamburg, Germany.

FEBS Letters
|December 28, 1993
PubMed

Insights

Certain proline-directed kinases, including cdk5 (cyclin-dependent kinase 5), phosphorylate tau protein, mimicking changes seen in Alzheimer

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Proline-directed kinases like MAP kinase and GSK-3 phosphorylate tau protein abnormally, similar to Alzheimer's disease.
  • These kinases are abundant in brain tissue and associate with microtubules.

Purpose of the Study:

  • To investigate other proline-directed kinases involved in tau phosphorylation.
  • To identify kinases responsible for Alzheimer's-like tau modifications.

Main Methods:

  • Utilized an antibody against the conserved N-terminus of cdk-like kinases to isolate a brain kinase.
  • Phosphorylated recombinant tau protein with the isolated kinase.
  • Confirmed kinase identity using an antibody specific for cdk5.
  • Examined association with microtubules through assembly/disassembly cycles.

Main Results:

  • cdk2/cyclin A incorporated phosphate into tau, inducing Alzheimer's-like characteristics.
  • A novel cdk-like kinase isolated from brain induced similar Alzheimer's-like tau modifications.
  • This kinase, identified as cdk5, is abundant in brain and associated with microtubules.

Conclusions:

  • cdk5 (cyclin-dependent kinase 5) is a proline-directed kinase found in brain tissue.
  • cdk5 phosphorylates tau protein, inducing modifications characteristic of Alzheimer's disease.
  • cdk5 is implicated as a potential kinase responsible for tau protein changes in Alzheimer's disease progression.

Related Concept Videos